Indolotryptoline compounds of the general structure: (Formula I) are disclosed. In these compounds R1 is chosen from hydrogen, halogen and OH; R2 is (C1-C4)alkoxy; and R3 is chosen from hydrogen and halogen. The compounds are useful for treating cancer.